Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis
about
Future perspectives in target-specific immunotherapies of myasthenia gravisNeuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE).CD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis.Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity.GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravisDual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy.Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosisAutoimmune myasthenia gravis.Development of novel therapies for MG: Studies in animal models.Treatment strategies for myasthenia gravis: an update.Biologics and other novel approaches as new therapeutic options in myasthenia gravis: a view to the future.Age-dependent divergent effects of OX40L treatment on the development of diabetes in NOD mice.Antigen-specific immunoadsorption of anti-acetylcholine receptor antibodies from sera of patients with myastenia gravis.Identification of a Novel OX40L Dendritic Cell Subset That Selectively Expands Regulatory T cells
P2860
Q26776225-46DDE32C-49DE-4688-94D1-EB05D1371941Q31044261-D4676097-4E0F-40DA-9312-3B04F2996596Q34204228-33D5C235-30BE-459F-AD06-A2B3635949DEQ35294492-E58723F8-58AA-41DC-8814-F307367771A1Q35603050-03716A97-3FC7-4504-8BA7-B27E9ECDFBE5Q35928330-1930B9A0-2AFD-4C13-A30B-9FA228E6D6B0Q36174813-4107194F-92FD-49CF-99D0-ADF247DDDBBAQ37409490-BA86AFB1-1A3E-4282-B145-2AD3DB7B2DB8Q37713733-56E33A01-50C9-4259-9C69-88195F99A7A3Q38024858-B527DEE3-B3F0-45EB-9159-F9B729770067Q38068530-C2577DD9-231B-44B8-9CFB-286F0C9F6068Q41233136-3D40A463-51C1-45DA-9823-AD87CB5E3158Q43145001-EC2A9733-CCC2-4B19-A202-379523545FB9Q57296151-F4326F83-9737-418D-83CA-7CFD51C2E2F9
P2860
Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis
@en
Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis.
@nl
type
label
Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis
@en
Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis.
@nl
prefLabel
Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis
@en
Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis.
@nl
P2093
P2860
P356
P1476
Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis
@en
P2093
Bellur S Prabhakar
Jian Rong Sheng
Liangcheng Li
Matthew N Meriggioli
P2860
P304
P356
10.1196/ANNALS.1405.023
P407
P577
2008-01-01T00:00:00Z